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Virtually everyone working in cancer research is familiar with the “Warburg effect”, i.e., anaerobic glycolysis in the
presence of oxygen in tumor cells. However, few people nowadays are aware of what lead Otto Warburg to the
discovery of this observation and how his other scientific contributions are seminal to our present knowledge of
metabolic and energetic processes in cells. Since science is a human endeavor, and a scientist is imbedded in a
network of social and academic contacts, it is worth taking a glimpse into the biography of Otto Warburg to
illustrate some of these influences and the historical landmarks in his life. His creative and innovative thinking and
his experimental virtuosity set the framework for his scientific achievements, which were pioneering not only for
cancer research. Here, I shall allude to the prestigious family background in imperial Germany; his relationships to
Einstein, Meyerhof, Krebs, and other Nobel and notable scientists; his innovative technical developments and their
applications in the advancement of biomedical sciences, including the manometer, tissue slicing, and cell
cultivation. The latter were experimental prerequisites for the first metabolic measurements with tumor cells in the
1920s. In the 1930s–1940s, he improved spectrophotometry for chemical analysis and developed the optical tests
for measuring activities of glycolytic enzymes. Warburg’s reputation brought him invitations to the USA and
contacts with the Rockefeller Foundation; he received the Nobel Prize in 1931. World politics and world wars
heavily affected Warburg’s scientific survival in Berlin. But, after his second postwar recovery, Warburg’s drive for
unraveling the energetic processes of life, both in plants and in tumor cells, continued until his death in 1970. The
legacy of Otto Warburg is not only the Warburg effect, but also the identification of the “respiratory ferment” and
hydrogen-transferring cofactors and the isolation of glycolytic enzymes. His hypothesis of respiratory damage being
the cause of cancer remains to be a provocative scientific issue, along with its implications for cancer treatment
and prevention. Warburg is therefore still stimulating our thinking, as documented in a soaring increase in
publications citing his name in the context of tumor metabolism.
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Background
The work of Otto Heinrich Warburg has been having a
profound influence on the way we think about tumor
metabolism. Particularly, in the field of cancer research,
we are using the term “Warburg effect” to denote a
metabolic phenotype typical of many tumor cells,
namely the high activity of anaerobic glycolysis, i.e., pro-
duction of lactic acid, even in the presence of sufficient
oxygen. Originally however, this term was first used in
1962 in plant physiology to denote the inhibition of
CO2-fixation by oxygen in photosynthesis [1]. It was
then Efraim Racker who in 1972 in his publication on
the bioenergetics of tumor growth coined the presence
of high aerobic glycolysis in tumors as the Warburg ef-
fect [2]. Yet, this term was not generally used in this
context until about 30 years later. Especially during the
last 15 years, the number of publications using the term
Warburg effect in cancer research has risen quasiCorrespondence: otto@tum.de
Institute of Medical Engineering (IMETUM), Technische Universitaet
Muenchen, Boltzmannstr. 11, D-85748 Garching, Germany
© 2016 Otto. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Otto Cancer & Metabolism  (2016) 4:5 
DOI 10.1186/s40170-016-0145-9
exponentially, a sign of the renaissance of tumor metab-
olism (Fig. 1).
But, who was the man behind the Warburg effect?
What were his scientific achievements, and which of
these lead to the discovery of this “effect” almost a cen-
tury ago? And, in which scientific context does his work
appear today?
An illustrious personal background
To better appreciate Warburg’s ground breaking experi-
mental achievements and his way of thinking, it is
worthwhile going into his personal history, recounting
which influences his family background as well as his so-
cial and scientific environment had on him. Otto Hein-
rich Warburg (not to be confused with his uncle Otto
Warburg, a botanist) was born on October 8, 1883 in
Freiburg in Breisgau, a city with a traditional university
in southwestern Germany. His father, Emil Warburg, at
that time an eminent Professor in Physics at the Univer-
sity of Freiburg, belonged to a widespread Jewish family
(which in the sixteenth century had settled in the
German town of Warburg), but he had become a Prot-
estant. Otto’s mother, a sociable and resolute person,
came from a South German family of military and gov-
ernmental officials. Therefore, his parents were predes-
tined to educate him and his three sisters in an
intellectually and culturally stimulating environment
with a gracious lifestyle typical of the academic class
during the imperial reign of Germany. In 1896, the fam-
ily moved to Berlin, where Emil Warburg had become
Director of the Institute of Physics at the University of
Berlin. Through his membership in the prestigious Prus-
sian Academy of Sciences, he was in close contact with
scientific colleagues such as Albert Einstein and Max
Planck. The house of the Warburgs was the site of vi-
brant social evenings, where Einstein played the violin,
Planck played the piano and other colleagues such as J.
H. van’t Hoff and Walter Nernst contributed to the mu-
sical, literary, and philosophical entertainment. No
doubt, these guests seeded and fostered Otto’s interest
in natural science and molded his personality. His con-
temporaries later would not only describe him as a
charming, humorous, and generous person, but also as
being eccentric as well as polemic and vindictive toward
his opponents, as lacking modesty and not accepting any
criticisms of his ideas. Certainly, his extraordinary
intelligence, his disciplined style of working and living,
and his sharp mind were outstanding characteristics as a
scientist (biographical notes in this article were taken
from Krebs, Schmid [3], and Werner [4]).
Otto Warburg decided to study chemistry and left
Berlin in 1901 to enroll at the University of Freiburg,
from where he returned in 1903 to become a student of
Emil Fischer. Fischer had just received the Nobel Prize
the year before for the synthesis of sugars and purines;
he was a demanding teacher, requiring precision in ex-
periments and thinking, and perseverance in science. In
his lab, Warburg worked on the chemistry of glycine,
alanine, and leucine, for which he received his doctoral
degree in 1906. With this scientific foundation—and the
advice of his mother not to marry (marriage being in-
compatible with the life of a scientist)—Otto Warburg
was well on his way to a promising scientific career.
But, Warburg first wanted to know more about the
processes in life and thus went to the University of
Heidelberg to study medicine with Ludolf Krehl, Profes-
sor of Pathophysiology. There, he also got acquainted
with Julian Huxley, an evolutionary biologist, with Viktor
von Weizsäcker, a founder of psychosomatic medicine,
as well as Archibald Vivian Hill and Otto Meyerhof.
Warburg wanted to apply the concepts and methods he
had acquired in chemistry and physics to understand the
energetic processes of life. He started experimenting
with different types of cells: bacteria, yeast, and red
blood cells. During the summers of 1908 to 1911, often
along with Meyerhof, he visited the Marine Station in
Naples (Italy), where he made his first remarkable obser-
vations with sea urchin eggs; he found that oxygen con-
sumption was increased six- to sevenfold after the eggs
had been fertilized and was strongly inhibited by cyanide
and narcotics. This work converged into a second doc-
toral thesis in 1911 on the oxidation of live cells per-
formed with sea urchin eggs as a model system [4]. In
1913, he acquired the qualifications for a professorship
in physiology (“Habilitation”) on the topic of energy-
delivering reactions in live cells.
Establishing a scientific career
In 1913, Warburg decided to return to Berlin, where the
Kaiser Wilhelm Institute (KWI) had been founded and
Fig. 1 Number of publications per year found in the Web of Science
with the search words “Warburg effect” AND (cancer OR tumor)
Otto Cancer & Metabolism  (2016) 4:5 Page 2 of 8
of which his previous mentor Emil Fischer was the Vice-
President. With the support of such notable scientists as
Paul Ehrlich (who recognized the importance of basic
cancer research), Theodor Boveri (who had hypothesized
that cancer was due to chromosomal damage) and Jacob
Loeb (a friend of the Warburg family and a German
emigrant working at the Rockefeller Institute in New
York on sea urchin parthenogenesis), Otto Warburg came
to be a member of the KWI. He got a position as a princi-
pal investigator at the new Institute of Biology—with the
freedom to choose his research topic. Since he disliked
teaching obligations as well as working in the industry,
this was the ideal position for him.
At the outbreak of the First World War in 1914,
Warburg felt a traditional and national obligation to serve
the country, and he volunteered—much to the dismay of
his mother. He was installed as a physician in an elite cav-
alry unit. In 1918, after having been wounded, Otto’s
mother now insisted that her son could do more good for
his country by going back to science rather than to the
battle-field. So, she wrote to Albert Einstein to support
her mission in convincing the ministry—and her son. And
indeed, upon receiving a letter from Einstein, Warburg
returned to Berlin and to the lab bench. Moreover, to re-
lieve him of organizing his daily life at home, Otto’s
mother now organized a personal aid, a reputable young
man named Jacob Heiss. Eventually, he would also be
Warburg's secretary, doing the unavoidable administrative
work of the institute and becoming a loyal friend accom-
panying Warburg for the rest of his life.
In spite of the thwarted financial state after the First
World War, Warburg managed to continue his research.
The German government had established funds for sup-
porting research of scientists in precarious economic sit-
uations. Warburg asked for such funding on the
telephone, but a written application was required. So
Warburg dictated his text to a secretary which had been
hired for this purpose; the application consisted of a sin-
gle page and had the following content:
Dr. Otto Warburg.
Application
I need ten thousand Marks.
Otto Warburg
The money was granted.
Of the long scientific career that followed, only a few
highlights can be alluded to in this short summary of
Otto Warburg’s life and work. His outstanding achieve-
ments evolved from the synthesis of excellent experi-
mental training and innovative thinking, which
circumvented around two basic questions. (1) What are
the energetics of life? (2) Is there a quantitative differ-
ence in the metabolism of cancer cells and normal cells?
For the experimental, i.e., technical setup, he recruited
not academics with ambitions for their own career, but
rather professionals trained in fine mechanics, capable of
constructing the particular devices needed for investiga-
tions with tissue and cells; they were frequently coau-
thors of his publications. Otto Warburg profited from
his father in having learned to work with a manometer,
with which it was possible to measure in solution CO2
production and O2 consumption. By providing a
temperature control and a shaking mechanism to ensure
rapid diffusion in the medium, the device was modified to
serve the specific requirements for measuring live tissues
and cells. Since the tissue needed a standardized thickness,
he calculated the number cell layers which allowed for
sufficient diffusion of glucose and O2, and developed a
mechanism for preparing tumor slices of <0.5 mm—a
method still in use today. Moreover, by parallelizing
the setup, it was possible to measure multiple samples
at the same time. These technical innovations allowed
Warburg and his coworkers to perform the pioneer-
ing experiments leading to metabolic concepts still
being investigated today.
For the scientific part, Warburg had intelligent and
motivated PhD students and postdocs (wissenschaftliche
Assistenten). Warburg’s lab was open to visiting scien-
tists, among them being David Keilin (who had discov-
ered the cytochromes), Archibald Vivian Hill (working
on O2-consumption in muscle), Hugo Theorell (a
Swedish biochemist working on oxidizing enzymes),
Fritz Albert Lipmann (discoverer of coenzyme A), and
Severo Ochoa (a Spanish biochemist working on biosyn-
thesis of nucleic acids) [4]. It is fortunate that Hans
Krebs, who worked in Warburg’s lab from 1926 to 1930
and maintained a long standing relationship with him,
recollected Warburg’s life in a biography illuminating his
personality and scientific achievements [3].
First observations on tumor metabolism
In 1923, Otto Meyerhof and Archibald V. Hill received
the Nobel Prize for work on the energetics of muscle
metabolism, in particular for the discovery of the rela-
tionship between oxygen consumption and lactic acid
metabolism. In the same year, Otto Warburg and Seigo
Minami published the first observations on changes in
the metabolism of tumors [5]. They had observed that
tumors acidified the Ringer solution (an isotonic salt so-
lution, with 2.4 mM NaHCO3) when 13 mM glucose
was added, as indicated by a change in the color of or-
ganic pH-indicators. In this acidified solution, lactic acid
was chemically identified. To better quantify this
phenomenon, Otto Warburg modified the Barcroft man-
ometer to measure slices of a Flexner-Jobling rat
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hepatoma, which he had received from Rhoda Erdmann
at the Rockefeller Institute. The amount of lactate pro-
duced was calculated from the increase in CO2-forma-
tion during a 30-min incubation period. Surprisingly, the
tumor tissue had a 70-fold higher rate of lactate forma-
tion than the normal liver as well as kidney and heart
tissue likewise tested. This is the observation that would
more than 50 years later be referred to as the Warburg
effect. Lactate production did not depend on the pres-
ence of oxygen. That had not been expected, since ac-
cording to Pasteur, the presence of oxygen should have
suppressed glycolysis. The fact that there appeared to be
no direct relationship between respiration and glycolysis
lead to the conclusion that in cancer cells, glycolysis was
a reaction which could produce energy, independent of
respiration (oxygen consumption). In other experiments
with varying glucose and bicarbonate concentrations, it
was shown that there was no generalizable difference in
oxygen consumption between the tumor and the re-
spective normal epithelial tissue [6]. In 1924, Warburg
hypothesized that there was a defect in the relationship
between glycolysis and respiration. Even though this ob-
servation was corroborated with other tumors by several
contemporary scientists [7], the observation that oxygen
could not suppress glycolysis prompted him to propose
that a damage in respiration leads to carcinogenesis [8].
This came to be a highly controversial issue climaxing in
his famous papers in Science in 1956 [9].
Testing the effects of other parameters, Warburg and
coworkers changed the pH of the Ringer solution ran-
ging from pH 7.83 to 6.66 using 1–15 % CO2-N2 gas
mixtures, respectively. The rate of CO2-production
(interpreted as glycolysis) increased with increasing alka-
line pH. Moreover, a tenfold increase in bicarbonate
concentration at a defined pH of 7.5 also increased CO2
production [10]. Warburg interpreted these conditions
as being similar to those in blood passing through capil-
laries, leading at the same time to a modest acidification
and to an increase in bicarbonate concentration. In the
balance, glycolysis of the tissues would not change. On
the other hand, other studies showed that in tissue ho-
mogenates, alkalinity increased with dedifferentiation
and necrosis of tumors [11], suggesting that the tumor
itself may have a different pH. However, the influence of
pH on the growth of tumor cells appeared never to be of
particular interest to Warburg, in spite of his interest in
hydrogen-transferring systems such as the coenzymes
NAPDH and NADH (see below), which lead to the
characterization of the activity of most glycolytic en-
zymes in later years.
Warburg corroborated his in vitro results in rats hav-
ing either a hepatoma or sarcoma, where he found a
higher lactic acid content (chemically determined) in
blood vessels leaving the tumor than in vessels entering
the tumors [12]. Similar experiments had been per-
formed by Carl and Gerty Cori [13], who also found dif-
ferent lactic acid levels in the blood of the two wings of
same chicken: one with the implanted tumor and one
without it. Warburg’s interpretation was that a lack of
oxygen (hypoxia), along with an increase in lactic acid,
favored the survival of tumors as opposed to normal
cells, since the latter could not recruit their energy from
anaerobic glycolysis. In other words, his hypothesis was
that chronic hypoxia would damage respiration. The
basis for this line of thinking was that, according to the
Pasteur Effect, the presence of oxygen should (com-
pletely) suppress glycolysis. Since this was not the case
in tumor cells, he concluded that there were “distur-
bances in the relationship between respiration and gly-
colysis” [10]. In 1930, Warburg reinforced his hypothesis
in stating that anaerobic glycolysis of tumor cells is the
result of respiratory damage (Schädigung) [14]. This
issue was critically discussed by Dean Burk at a Cold
Spring Harbor Symposium on Quantitative Biology in
1939, where he presented a collection of data from dif-
ferent tumors showing that tumor cells also displayed a
Pasteur Effect since a fraction of glycolysis was indeed
attenuated by oxygen, often to a similar extent as in nor-
mal growing cells [15].
Even though Warburg was also nominated for the No-
bel Prize in 1926—for which he considered himself duly
eligible—the Nobel committee decided to award it solely
to Johannes Fibiger, honoring his findings on a gastric
tissue growth condition believed to be a cancer induced
by a nematode (spiroptera carcinoma). This has been
considered as a misjudgment of the Nobel committee, as
it later turned out not to be true [3, 16].
The respiratory ferment
Along with the basic questions on what kind of changes
in energy metabolism convert normal cells to tumor
cells, Warburg was interested in the chemical basis for
the “respiratory ferment” responsible for oxygen transfer
in cells. Warburg had already postulated in 1914 that
iron had a catalytic function in cellular respiration. Also,
Warburg knew David Keilin, who (in 1925) had spectro-
scopically detected three cytochromes with iron-
containing porphyrins (hemins) in respiring cells. Since
the available amount of the ferment was too small for
analytical chemistry, Warburg applied an “inhibition
technique” by using two substances having specific in-
hibitory effects: hydrocyanic acid and carbon monoxide
(CO), the first inhibiting respiration irreversibly, the lat-
ter reversibly depending on O2-pressure [17]. Visiting
Warburg’s lab, Alan Hill brought to his attention that
the inhibition of respiration by CO was light-sensitive.
This allowed Warburg to characterize the oxygen-
sensitive ferment by relating changes in the absorption
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coefficient determined by spectrometry with increases in
the respiratory activity upon increasing the illumination
[17]. In this way, Warburg identified cytochrome a3
(cytochrome oxidase) as being the CO-sensitive respira-
tory enzyme, i.e., the one requiring oxygen. Today, we
know that there are indeed five proteins with iron for
the electron transport and that cytochrome oxidase is
part of complex IV. Warburg furthermore postulated the
respiratory proteins to be localized in the “grana” of
cells, which years later were identified as mitochondria.
Reduction processes in metabolism
It was quite clear that if there were oxidative processes
in life, there must also be reductive reactions, i.e., a
transfer of hydrogens. From the beginning of the twenti-
eth century, it was already known that some enzymes re-
quired hydrogen-mediated activation. While O2 was
considered to be the physiological acceptor in the re-
spiratory process, live cells were also able to reduce the
non-physiological molecule methylene blue to a color-
less compound in the presence of hydrogen donors such
as succinate, malate, citrate, or glutamate. However,
Warburg doubted that this synthetic methylene blue re-
duction reflected a physiological process until he visited
E.S. Guzman Barron in his laboratory at the Johns Hop-
kins School of Medicine in Baltimore, USA, in 1929.
They performed experiments with rabbit red blood cells
(i.e., non-respiring cells), which were incubated with glu-
cose and oxygen. The result was the production of pyru-
vate and CO2 along with the reduction of methylene
blue [3]. Subsequently, Warburg sought for the chemical
basis of this reaction. Having discovered that cell lysates
incubated with phosphorylated glucose were also able to
oxidize methylene blue, he now had an in vitro system
for separating the components involved. Upon dialysis of
the reaction solution, two essential molecular entities
were discerned: (1) a heat-stable low molecular weight
component, the coenzyme, and (2) a high molecular
weight component, the enzyme. The latter actually con-
tained a “yellow ferment”, which turned out to be a
phospho-riboflavin, a nucleotide which is the prosthetic
group of flavoproteins and can be reversibly hydroge-
nated and dehydrogenated.
As to the other low molecular compound, only a few
milligrams had been isolated from red blood cells out of
200 l of horse blood. Three constituents of this molecule
were soon identified as being phosphate, adenine, and a
pentose; but one component remained elusive and its
identification needed more material. As the anecdote
from Hugo Theorell goes, Warburg (who loved and rode
horses) had calculated that to have enough substance
purified for further chemical analysis, he would need the
blood from all the horses in Germany. Since Warburg
was a very meticulous scientist in documenting all the
measured physical and analytical parameters, his close
friend Walther Schoeller (who worked for Schering on
the “cancer problem”) suggested looking in the “Beil-
stein”, an encyclopedia of organic chemistry, for a corre-
sponding compound. Indeed, there, he found it; it had
already been synthesized in 1878 and was cheaply com-
mercially available: nicotinamide [3, 18]. The complete
molecule exists in either its phosphorylated or non-
phosphorylated form, today known as NADPH and
NADH, respectively, and is the catalytic active group for
hydrogen transfers in about 150 known enzymes, i.e., de-
hydrogenases and NAD(P)H-oxidases. Moreover, War-
burg hoped this coenzyme would have anti-cancer
effects. This was not to be the case; but it was the basis
for a medication against tuberculosis [4].
Together with the physicist Manfred von Ardenne,
Warburg had improved the sensitivity of the spectrom-
eter (1934/1935), which allowed him to measure the
light absorbance spectra of these pyridine nucleotides.
The discovery of differences in the spectral lines with
the state of hydrogenation opened novel possibilities to
measure the activity of enzyme reactions, which involved
the transfer of molecular hydrogens from or to these
pyridine nucleotides. This NADH resp. NADPH-linked
analysis was the advent for measuring numerous enzyme
activities, today known as the optical test. Indeed, over
the next 10 years, using this assay, Warburg was the first
to crystalize and characterize 9 of the 13 glycolytic en-
zymes already known by the reactions they catalyzed.
Among them are lactate dehydrogenase, enolase, glycer-
aldehyde phosphate dehydrogenase (GAPDH), and pyru-
vate kinase—all key enzymes now again being studied in
cancer metabolism. Further technical improvements on
the photometer in cooperation with California-based
Beckman Instruments made the device commercially
available, and thereby this optical test became a world-
wide enzymatic and analytical tool.
The founding of the Institute of Cell Physiology in
Berlin and world politics
Warburg deemed academic tourism a waste of time, but
he did make two visits to the USA in the 1920s, visits
which would have profound consequences on his career.
On the first occasion in 1924, he visited Jacob Loeb, a
friend of the Warburg family, at the Rockefeller Institute
in New York, and gave talks also at other universities. In
1929, he was guest in the laboratory of Barron at Johns
Hopkins Medical School, where he performed the exper-
iments on the enzymatic nature of chemical reductions
in blood cells. On this visit, with the support of Jacob
Loeb, he also negotiated with the Rockefeller Founda-
tion, who was interested in establishing research insti-
tutes in Germany. In 1930, the Rockefeller Foundation
offered US$665,000 to the KWI for building two new
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institutes in Berlin: one for physics and one for cell
physiology. The Institute of Cell Physiology was inaugu-
rated in December 1931 and Otto Warburg became to
be its one and only director.
The year 1931 was also the one in which Otto
Warburg received the Nobel Prize in Medicine and
Physiology for unraveling the oxygen-transferring fer-
ment of respiration [17]. His father had missed this
event by only a few months, having died in July.
A controversial and enigmatic issue is how Warburg
could continue working in Berlin during the Third
Reich, since his Jewish colleagues had departed or been
expelled. Warburg himself was half-Jewish, but like his
father considered himself to be a German Christian and
even denied being related to the other Jewish descen-
dants in the family. On the other hand, he was quite
aware of the political situation from the very beginning
and supported his Jewish coworkers in getting jobs out-
side of the country; he advised Hans Krebs to take a pos-
ition in England. His rather disrespectful behavior
toward a visiting governmental official jeopardized the
institute being delivered with required chemicals. More-
over, in 1941, he was to be removed from his position as
a director. However, probably mediated through indirect
contacts to officials close to Hitler, he was allowed to
keep this position and continue working in the institute.
One explanation proposed for this salvation is that Hit-
ler, having had a benign larynx polyp removed, was
obsessed with cancer phobia and probably hoped for a
rapid cure to be discovered. The institute was declared
as a Service for Military Requirements (transliteration of
“Wehrbetrieb”) with the mission to work on cancer ther-
apies. In 1943, due to the bombings on Berlin, Warburg
along with very few remaining coworkers had to move
the laboratory to a small location in the countryside
northwest of Berlin [4].
After the war, it took some years until Warburg could
go back to acceptable working conditions. The Russians
had confiscated the laboratory equipment. His institute
in Dahlem (in West Berlin) was occupied by American
troops. He was examined on his role in Nazi Germany.
However, he finally was elected as a member of the
Academy of Sciences (reestablished in East Berlin), of
which his father along with Albert Einstein and Max
Planck had already been members. Warburg had job of-
fers from Russia, the USA, and from other countries and
several German cities. Eventually, in 1948, he traveled to
the USA, accepting the invitations from Robert Emerson
at the University of Illinois and Dean Burk at the Cancer
Institute at Bethesda to perform experiments on photo-
synthesis in their laboratories. In the summer of 1949,
he also visited Woods Hole in Cape Cod and the Cancer
Institute at Bethesda, where he met friends, expatriates,
and critical colleagues, with anecdotal incidences of
polemic scientific disputes. Returning to Berlin, he re-
covered “his” institute in 1950, which in 1952 was con-
verted into a Max Planck institute, where he continued
working until his death in 1970 [4].
Concepts on tumor metabolism, the origin of
cancer and its prevention
During the last period of his life, Warburg continued
working on both photosynthesis and tumor metabolism,
particularly on the role of respiration in tumorigenesis.
For the latter, he now also used cultures of cells which
had been isolated from normal tissues by trypsinization
based on a method which had just been developed by
Dulbecco and Vogt [19, 20]. Warburg reiterated his hy-
pothesis on the cause of cancer, claiming that “the res-
piration of all cancer cells is damaged” in his famous
Science paper [9]. Aspects of the controversial debate
that followed are documented in a subsequent Science
issue [21–23]; the disparate points of view appear to
evolve from different understandings on defining the
“damage” of mitochondria or the “chicken and the egg.”
Moreover, Warburg published his ideas on the primary
(ultimate) and secondary (distant) causes of cancer
(transliteration of “Ueber die letzte Ursache und die
entfernten Ursachen des Krebses”): while there are un-
countable secondary causes, almost everything causing
cancer, including time, the primary cause is the replace-
ment of cell respiration by fermentation, i.e., lactate for-
mation (quoted in [3]). He presented these concepts at
prestigious meetings, one being the Annual Meeting of
the Nobel Laureates in 1966 in Lindau, an island in the
Lake of Constance (Germany). On this occasion, he re-
ceived much scientific dissent. His idea that the causa-
tive problem of cancer cells was solely one of energetics
and at the level of the respiratory system was not con-
vincing in view of the fact that it contradicted Warburg’s
own initial data and similar results from many others,
and that it disregarded the more recent discoveries on
the altered genetics of cancer cells leading to unregu-
lated proliferation and tumor growth. It is inferred that
Melvin Calvin, who had received the Nobel Prize on
photosynthesis in 1961 and had expanded his interests
to carcinogenesis, may have avoided these harsh con-
frontations with Warburg by not attending the Lindau
meetings until 1974, after the death of Warburg [24].
Warburg claimed that 80 % of cancers could be avoi-
ded—simply by reducing the level of carcinogens [25].
Warburg considered cancer to be a nutritional problem,
one that could be avoided by maintaining an appropriate
natural diet. As early as 1923, Warburg and Schoeller
discussed starving cancer by drugs leading to “nutri-
tional deprivation” [4]. In his last publication in 1970, he
claimed that a cause for spontaneous “tumor metabol-
ism” was either a lack of oxygen or a lack of vitamin B1
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(thiamin)—both conditions increasing the production of
lactic acid [25]. This line of thinking led him to consider
the administration of vitamin supplements, which would
enhance respiration and was considered to be a natural
and safe application. Already in the 1940s, Warburg,
who was asserted having cancer phobia, practiced his
own recommendations in maintaining a disciplined life-
style: he grew his own vegetables, drew water from an
unpolluted well, had his bread baked with grains from
wheat not treated with pesticides, and kept his own
poultry. And, he did sports: long walks, horseback rid-
ing, or sailing [3]. After his favorite sister Lotte died of
cancer in 1948, Warburg also quit smoking [4].
Warburg, being sensitized to the dangers of smoking, al-
cohol, and drugs, proposed to the German Ministry of
Health to reduce cigarette smoking, motor vehicle ex-
hausts, air pollution, and chemical additives in foods as
cancer prevention measures. This was in 1954 and at
that time without avail [3].
Conclusions
What are the effects of Warburg’s work and ideas on
cancer research today? For one, there is the Warburg ef-
fect, i.e., the observation that tumors have a high rate of
glycolysis, namely lactate production, in the presence of
oxygen. While this is a reproducible observation, the sci-
entific controversies continue on how the Warburg ef-
fect is related to the origin of cancer, what it means in
molecular terms, how it can be connected to the genom-
ics, proteomics, and molecular biology of cancer cells,
and last but not least, how it can be utilized for diagnos-
tics and therapy. The renaissance of the Warburg effect
has put cancer metabolism back into the lime light of
cancer research. Several recent reviews have drawn a
bridge between Warburg’s original work and many as-
pects of molecular cancer metabolism and signaling
pathways required for tumorigenesis known today (for
example: [26–30]).
Probably the most controversial legacy for tumor me-
tabolism is the hypothesis on the origin of cancer: that
damaged respiration is solely responsible for the tumor
type metabolism. In spite of its disaffirmation by numer-
ous data and alternative explanations [31] providing evi-
dence that there are also tumor cells which have
apparently normal mitochondria and respiratory activity,
what makes this hypothesis so attractive? A popular hy-
pothesis always has two sides. The shiny side of the coin
is the myriad of ideas it evokes and the new experiments
and concepts it stimulates, especially when the hypoth-
esis comes from a Nobel Laureate. On the other side,
however, there is the danger of oversimplification and
non-reflected universal application, as well as the uncrit-
ical acceptance of a hypothesis as a given fact. For the
latter, Warburg alone cannot be held responsible—it is
the challenge and responsibility of every scientist to
question the validity of a hypothesis. We now have avail-
able many new investigative tools allowing us to elabor-
ate on the observations and conclusions made by Otto
Warburg about 90 years ago. He has set an example of
meticulous work, bringing forth a gain of knowledge,
which is now taken for granted as common textbook
knowledge. He has, moreover, set an example for ingeni-
ous thinking, even if not all of it has been proven right.
“Truth is more likely to come out of error if it is clear
and definite, than out of confusion, and my experience
teaches me that it is better to hold a understood and in-
telligible opinion, even if it should turn out to be wrong,
than to be content with a muddled-headed mixture of
conflicting views, sometimes called impartiality, and
often no better than no opinion at all.” (Warburg quoted
by Krebs, Schmid [3], p.83). Reflecting this statement
could also be a Warburg effect.
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